SPICKSCHEN THORLEF 4
4 · Clovis Oncology, Inc. · Filed Mar 9, 2018
Insider Transaction Report
Form 4
SPICKSCHEN THORLEF
Director
Transactions
- Sale
Common Stock
2018-03-08$61.47/sh−4,500$276,615→ 12,118 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2017.